David Hardisson - Concepedia

Author

David Hardisson

Also Known As

Andrés Redondo, D HARDISSON, D Hardisson, D. A. Hardisson, D. HARDISSON, D. Hardisson, DAVID HARDISSON, David Hardisson, Jones, M, Laura Yébenes

294

Publications

9.9K

Citations

H-Index

107

Concepts

All Affiliations

Hospital Universitario La Paz Universidad Autónoma de Madrid Spanish National Cancer Research Centre Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Cáncer

About

David Hardisson is an author at Hospital Universitario La Paz specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	42	3.7K
2	Health Sciences	6	6	273
3	Engineering	5	5	349
4	Natural Sciences	1	1	73
5	Public Health	1	1	59

David Hardisson

101

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype David Sarrió, Socorro Marıá Rodríguez-Pinilla, David Hardisson, Cancer Research Epithelial-mesenchymal TransitionEmt MarkersBreast OncologyOncologyEmt Process	2008	1.1K
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation Maria Vinci, Sharon Gowan, Frances Boxall, BMC Biology	2012	985
Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas Socorro Marıá Rodríguez-Pinilla, David Sarrió, Emiliano Honrado, Clinical Cancer Research	2006	324
<i>FGFR1</i> Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas Jorge S. Reis‐Filho, Peter T. Simpson, Nicholas C. Turner, Clinical Cancer Research	2006	266
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer Socorro Marıá Rodríguez-Pinilla, David Sarrió, Gema Moreno‐Bueno, Modern Pathology Possible DriverLineage PlasticityBreast OncologyMedicineSporadic Breast Cancer	2007	244
Abnormalities of the APC/β-catenin pathway in endometrial cancer Gema Moreno‐Bueno, David Hardisson, Carolina Sánchez, Oncogene Tumoral PathologyGynecologyEndometrial CancerMedicineCancer Research	2002	235
The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients Susanna Leskelä, Luis J. Leandro‐García, Marta Mendiola, Endocrine Related Cancer	2010	207
Epigenetic and genetic alterations of <i>APC</i> and <i>CDH1</i> genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instability David Sarrió, Gema Moreno‐Bueno, David Hardisson, International Journal of Cancer	2003	203
Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions David Sarrió, Belén Perez‐Mies, David Hardisson, Oncogene Breast OncologyOncologyMedicinePathologyMetastatic Lesions	2004	202
Lysyl Oxidase–Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas Héctor Peinado, Gema Moreno‐Bueno, David Hardisson, Cancer Research	2008	200

Page 1